Amiloidosis, a mysterious disease, still underestimated

Mircea Penescu1

  • 1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. mirceapenescu@yahoo.com

Insights

Amyloidosis remains a poorly understood disease characterized by amyloid fibril formation. This review highlights key aspects of amyloidosis, aiming to guide future research toward better therapies.

Area of Science:

  • * Medical research
  • * Protein misfolding diseases

Background:

  • * Amyloidosis, identified 150 years ago, is a complex disease with poorly understood mechanisms.
  • * The formation, persistence, and deposition of amyloid fibrils remain subjects of ongoing scientific debate.
  • * Characterized by severe symptoms and a poor prognosis, amyloidosis is often diagnosed late.

Purpose of the Study:

  • * To review the historical context and fundamental characteristics of amyloidosis.
  • * To discuss the proteins involved in amyloid fibril formation.
  • * To provide insights into pathogenesis, histology, diagnosis, and prognosis.

Main Methods:

  • * Literature review focusing on historical data and current understanding of amyloidosis.
  • * Analysis of scientific literature concerning amyloid fibril formation and deposition.
  • * Synthesis of information on diagnostic and prognostic aspects.

Main Results:

  • * Amyloidosis pathogenesis involves the misfolding and aggregation of specific proteins into amyloid fibrils.
  • * Histological examination is crucial for identifying amyloid deposits in tissues.
  • * Diagnosis relies on a combination of clinical presentation, imaging, and biopsy findings.

Conclusions:

  • * Despite 150 years of study, amyloidosis presents significant diagnostic and therapeutic challenges.
  • * Further research into the molecular mechanisms of amyloid fibril formation is essential.
  • * Enhanced understanding is needed to develop more effective treatments for amyloidosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...